Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Whitehawk Therapeutics (WHWK) Return on Assets (2019 - 2025)

Historic Return on Assets for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to 0.59%.

  • Whitehawk Therapeutics' Return on Assets rose 700.0% to 0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.63% for FY2024, which is 2100.0% down from last year.
  • As of Q3 2025, Whitehawk Therapeutics' Return on Assets stood at 0.59%, which was up 700.0% from 0.47% recorded in Q2 2025.
  • In the past 5 years, Whitehawk Therapeutics' Return on Assets ranged from a high of 0.02% in Q1 2021 and a low of 1.0% during Q2 2022
  • Over the past 5 years, Whitehawk Therapeutics' median Return on Assets value was 0.48% (recorded in 2023), while the average stood at 0.52%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -9800bps in 2021, then soared by 6200bps in 2023.
  • Whitehawk Therapeutics' Return on Assets (Quarter) stood at 0.67% in 2021, then surged by 53bps to 0.32% in 2022, then plummeted by -51bps to 0.48% in 2023, then plummeted by -69bps to 0.82% in 2024, then rose by 27bps to 0.59% in 2025.
  • Its last three reported values are 0.59% in Q3 2025, 0.47% for Q2 2025, and 0.39% during Q1 2025.